×
For best experience we recommend to activate Javascript in your browser.
Ferredoxin Reductase antibody (AA 33-451)
The Rabbit Polyclonal anti-Ferredoxin Reductase antibody has been validated for WB, ELISA and IHC. It is suitable to detect Ferredoxin Reductase in samples from Human.
Quick Overview for Ferredoxin Reductase antibody (AA 33-451) (ABIN7617125)
Target
See all Ferredoxin Reductase (FDXR) Antibodies
Ferredoxin Reductase (FDXR)
Reactivity
All reactivities for Ferredoxin Reductase antibodies
Human
Host
All hosts for Ferredoxin Reductase antibodies
Rabbit
Clonality
All clonalities for Ferredoxin Reductase antibodies
Polyclonal
Conjugate
All conjugates for Ferredoxin Reductase antibodies
This Ferredoxin Reductase antibody is un-conjugated
Application
All applications for Ferredoxin Reductase antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-Ferredoxin Reductase Antibody
(hide)
Binding Specificity
All epitopes for Ferredoxin Reductase antibodies
AA 33-451
Purpose
Fdxr Polyclonal Antibody
Characteristics
The Fdxr Polyclonal Antibody (Species: Human) has been validated for the following applications: ELISA, WB, IHC.
Purification
Protein G Purified
Purity
>95%
Immunogen
Recombinant Human Nadph:Adrenodoxin Oxidoreductase, Mitochondrial Protein
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
Lot specific
Buffer
Preservative: 0.03 % Proclin 300, Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for Ferredoxin Reductase
(hide)
Target
Ferredoxin Reductase (FDXR)
Alternative Name
FDXR
UniProt
P22570
Recently viewed
(hide)
Chat with us , powered by LiveChat